Literature DB >> 23481644

The mammalian clock and chronopharmacology.

Kristine Griffett1, Thomas P Burris.   

Abstract

Increases in our understanding of the molecular control of circadian rhythms and subsequent signaling pathways has allowed for new therapeutic drug targets to be identified as well as for a better understanding of how to more efficaciously and safely utilize current drugs. Here, we review recent advances in targeting components of the molecular clock in mammals for the development of novel therapeutics as well as describe the impact of the circadian rhythm on drug efficacy and toxicity.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23481644      PMCID: PMC4864859          DOI: 10.1016/j.bmcl.2013.02.015

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  51 in total

1.  The relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients.

Authors:  Kazufumi Iwata; Keiji Aizawa; Saori Sakai; Sachiko Jingami; Eiko Fukunaga; Minoru Yoshida; Akinobu Hamada; Hideyuki Saito
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

2.  The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1.

Authors:  Makoto Akashi; Toru Takumi
Journal:  Nat Struct Mol Biol       Date:  2005-04-10       Impact factor: 15.369

3.  Nuclear receptor expression links the circadian clock to metabolism.

Authors:  Xiaoyong Yang; Michael Downes; Ruth T Yu; Angie L Bookout; Weimin He; Marty Straume; David J Mangelsdorf; Ronald M Evans
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

4.  Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib.

Authors:  Ida Iurisci; Elisabeth Filipski; Hatem Sallam; Francis Harper; Catherine Guettier; Irène Maire; Moustapha Hassan; Stefano Iacobelli; Francis Lévi
Journal:  Chronobiol Int       Date:  2009-08       Impact factor: 2.877

Review 5.  Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.

Authors:  Francis Lévi; Christian Focan; Abdoulaye Karaboué; Virginie de la Valette; Danielle Focan-Henrard; Benoît Baron; Françoise Kreutz; Sylvie Giacchetti
Journal:  Adv Drug Deliv Rev       Date:  2007-07-04       Impact factor: 15.470

6.  Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.

Authors:  Laura A Solt; Yongjun Wang; Subhashis Banerjee; Travis Hughes; Douglas J Kojetin; Thomas Lundasen; Youseung Shin; Jin Liu; Michael D Cameron; Romain Noel; Seung-Hee Yoo; Joseph S Takahashi; Andrew A Butler; Theodore M Kamenecka; Thomas P Burris
Journal:  Nature       Date:  2012-03-29       Impact factor: 49.962

7.  Direct regulation of CLOCK expression by REV-ERB.

Authors:  Christine Crumbley; Thomas P Burris
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

8.  Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors:  Laura A Solt; Naresh Kumar; Philippe Nuhant; Yongjun Wang; Janelle L Lauer; Jin Liu; Monica A Istrate; Theodore M Kamenecka; William R Roush; Dušica Vidović; Stephan C Schürer; Jihong Xu; Gail Wagoner; Paul D Drew; Patrick R Griffin; Thomas P Burris
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

9.  Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.

Authors:  Katja A Lamia; Stephanie J Papp; Ruth T Yu; Grant D Barish; N Henriette Uhlenhaut; Johan W Jonker; Michael Downes; Ronald M Evans
Journal:  Nature       Date:  2011-12-14       Impact factor: 49.962

10.  Analysis of gene regulatory networks in the mammalian circadian rhythm.

Authors:  Jun Yan; Haifang Wang; Yuting Liu; Chunxuan Shao
Journal:  PLoS Comput Biol       Date:  2008-10-10       Impact factor: 4.475

View more
  9 in total

Review 1.  Circadian rhythm as a therapeutic target.

Authors:  Wei Ruan; Xiaoyi Yuan; Holger K Eltzschig
Journal:  Nat Rev Drug Discov       Date:  2021-02-15       Impact factor: 84.694

2.  Spatiotemporal separation of PER and CRY posttranslational regulation in the mammalian circadian clock.

Authors:  Peter C St John; Tsuyoshi Hirota; Steve A Kay; Francis J Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

Review 3.  The endogenous circadian clock programs animals to eat at certain times of the 24-hour day: What if we ignore the clock?

Authors:  Peng Jiang; Fred W Turek
Journal:  Physiol Behav       Date:  2018-04-16

Review 4.  Chronopharmacology of glucocorticoids.

Authors:  Megerle L Scherholz; Naomi Schlesinger; Ioannis P Androulakis
Journal:  Adv Drug Deliv Rev       Date:  2019-02-21       Impact factor: 15.470

Review 5.  Genetics of Circadian Rhythms.

Authors:  Martha Hotz Vitaterna; Kazuhiro Shimomura; Peng Jiang
Journal:  Neurol Clin       Date:  2019-05-29       Impact factor: 3.806

6.  The role of REV-ERB in NASH.

Authors:  Kristine Griffett; Matthew E Hayes; Michael P Boeckman; Thomas P Burris
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

7.  Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts.

Authors:  Shanbeh Zienolddiny; Aage Haugen; Jenny-Anne Sigstad Lie; Helge Kjuus; Kristine Haugen Anmarkrud; Kristina Kjærheim
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

8.  Phosphorylation and Circadian Molecular Timing.

Authors:  Andrea Brenna; Urs Albrecht
Journal:  Front Physiol       Date:  2020-11-26       Impact factor: 4.566

9.  The circadian clock modulates anti-cancer properties of curcumin.

Authors:  Ashapurna Sarma; Vishal P Sharma; Arindam B Sarkar; M Chandra Sekar; Karunakar Samuel; Michael E Geusz
Journal:  BMC Cancer       Date:  2016-09-29       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.